|
Incontinence episode frequency. |
||||||
| Treatment group (N)† |
Time point |
n‡ |
Median IEF/week |
Median percent change from baseline |
95% CI for median percent change in IEF |
P |
|
|
||||||
| Placebo (61) |
Baseline |
59 |
14.00 |
|||
| Endpoint |
6.25 |
|||||
| Change |
-5.63 |
-42.56 |
(-56.79,-33.89) |
|||
| Duloxetine (60) |
Baseline |
46 |
13.46 |
|||
| Endpoint |
4.12 |
|||||
| Change |
-7.25 |
-69.98 |
(-81.25,-53.57) |
< .001 |
||
|
† N = number randomized. ‡ n = number with diary data available for specified analysis. Abbreviations: CI = confidence interval; IEF = incontinence episode frequency. | ||||||
Lin et al. BMC Urology 2008 8:2 doi:10.1186/1471-2490-8-2 |
||||||